Portfolio lacks strategic focus
Clarify category, consumer tension, hero platforms, pricing logic and investment priorities.
Innovation & Growth Advisory
Turn science and consumer insight into products, margin and enterprise value.
For beauty, personal care, wellness, consumer health, ingredient, biotechnology and D2C businesses that need stronger innovation decisions and faster commercialization.
Client problems I solve
Innovation is slow or fragmented
Strengthen governance, stage-gates, decision rights, claims and cross-functional execution.
CDMO choices feel opaque
Evaluate capability, quality, scale, regulatory readiness, cost and supplier dependency.
Premiumization is not translating into margin
Connect proposition, formulation, packaging, claims, price architecture and channel economics.
Digital personalization lacks credibility
Define data logic, consumer value, scientific boundaries and commercial use cases.
Leadership needs enterprise influence
Build stronger narrative, decision quality, stakeholder alignment and innovation leadership systems.
Evidence base
Career scope includes Fortune 100 R&I leadership, founder P&L ownership, 40+ commercialized patents and innovations, BioAyurPro Fusion™ personalization, R&I digital transformation and multi-market innovation governance.
20% cycle-time reduction300–600 bps margin expansion enabled28.3% SAPMENA growth enabled€700M largest portfolio led
Bring the decision, not the presentation.
Start with a diagnostic or request a scoped sprint.